Soluble ADAM33 augments the pulmonary innate immune response promoting susceptibility to allergic airway inflammation

J. Kelly (Southampton, United Kingdom), E. Davies (Cincinnati, United States of America), X. Xu (Cincinnati, United States of America), J. Whitsett (Southampton, United Kingdom), D. Davies (Southampton, United Kingdom), H. Haitchi (Southampton, United Kingdom)

Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Kelly (Southampton, United Kingdom), E. Davies (Cincinnati, United States of America), X. Xu (Cincinnati, United States of America), J. Whitsett (Southampton, United Kingdom), D. Davies (Southampton, United Kingdom), H. Haitchi (Southampton, United Kingdom). Soluble ADAM33 augments the pulmonary innate immune response promoting susceptibility to allergic airway inflammation. 1103

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: